박영준 프로필 사진

박영준

Young Joon, Park

감염병위기관리국

위기관리총괄과

Web Of Science ORCID

자료 필터

자료유형

발행연도

2013 ~ 2026
2013 2026

키워드

언어

전체 53건 중 11번부터 20번까지의 결과를 표시합니다.

2023
Article

Age-specific Risk of SARS-CoV-2 Reinfection During Omicron Outbreaks, South Korea

  • 2023-08
  • Pediatric Infectious Disease Journal
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Analysis of pregnant women with critically severe COVID-19 in Republic of Korea from February 2020 and December 2021

  • 2023-04
  • Osong Public Health and Research Persptectives
  • KOREA DISEASE CONTROL & PREVENTION AGENCY
Article

Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study

  • 2023-03
  • Journal of Korean Medical Science
  • KOREAN ACAD MEDICAL SCIENCES
Article

BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 Years

  • 2023-03
  • JAMA Pediatrics
  • AMER MEDICAL ASSOC
Article

Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea

  • 2023-02
  • Osong Public Health and Research Persptectives
  • KOREA DISEASE CONTROL & PREVENTION AGENCY
Article

Positive Predictive Value of Rapid Antigen Tests in School During SARS-CoV-2 Omicron Variant Surge

  • 2023-01
  • Pediatric Infectious Disease Journal
  • LIPPINCOTT WILLIAMS & WILKINS
2022
Article

mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea

  • 2022-12
  • Osong Public Health and Research Persptectives
  • KOREA DISEASE CONTROL & PREVENTION AGENCY
Article

Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study

  • 2022-11
  • Journal of Medical Virology
  • WILEY
Article

Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents

  • 2022-11
  • Emerging Infectious Diseases
  • CENTERS DISEASE CONTROL & PREVENTION